BIAF
bioAffinity Technologies, Inc. NASDAQ Listed Sep 1, 2022$2.12
Mkt Cap $9.5M
52w Low $0.69
10.0% of range
52w High $15.00
50d MA $2.56
200d MA $3.38
P/E (TTM)
-0.2x
EV/EBITDA
0.3x
P/B
0.5x
Debt/Equity
0.2x
ROE
-204.9%
P/FCF
-0.2x
RSI (14)
—
ATR (14)
—
Beta
-0.81
50d MA
$2.56
200d MA
$3.38
Avg Volume
8.9M
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
22211 West Interstate 10 · San Antonio, TX 78257 · US
Data updated apr 24, 2026 9:37pm
· Source: massive.com